Scorpion Therapeutics, Inc. — Form D
Scorpion Therapeutics, Inc. of Boston, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-05-19. $24.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-05-19
- Form: D
- Accession: 0001811858-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $24.7M
- Investors: 11
- Date of first sale: 2020-04-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-367229
Issuer
- Name: Scorpion Therapeutics, Inc.
- CIK: 0001811858
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1 Winthrop Square, Boston, MA, 02110
- Phone: 781-288-5760
Officers, directors & promoters (24)
| Name | Role | Location |
|---|
| Shelley Chu | Director | Lexington, MA |
| Gary Glick | Director | LONDON, X0 |
| Gary Glick | Executive Officer | LONDON, X0 |
| Otello Stampacchia | Director | Boston, MA |
| Jean-Francois Formela | Director | Cambridge, MA |
| Andrew Fedder | Executive Officer | Boston, MA |
| Jeffrey Albers | Director | Boston, MA |
| Keith Flaherty | Director | Boston, MA |
| Adam Friedman | Director | Boston, MA |
| Adam Friedman | Executive Officer | Boston, MA |
| Brian Piper | Executive Officer | Boston, MA |
| Oleg Nodelman | Director | San Francisco, CA |
| Arjun Goyal | Director | Watertown, MA |
| Darrin Stuart | Executive Officer | Boston, MA |
| Erica Jackson | Executive Officer | Boston, MA |
| Amanda Valentino | Executive Officer | Boston, MA |
| Saurabh Saha | Director | Boston, MA |
| Mark Chao | Executive Officer | Boston, MA |
| Jean-Francois Joseph Formela | Director | Boston, MA |
| Arjun Joseph Goyal | Director | Boston, MA |
| Peter Joseph Campisi, Jr. | Executive Officer | Boston, MA |
| Keith Joseph Flaherty | Director | Boston, MA |
| Otello Joseph Stampacchia | Director | Boston, MA |
| Shelley Joseph Chu | Director | Boston, MA |
Other filings by this issuer (2)
More